Welcome to What I'd Tell My Family. In today’s episode, Dr. Todd Levine demystifies the latest advances in Alzheimer’s diagnosis, specifically, the new blood tests that can spot warning signs years before symptoms appear. These groundbreaking tests are creating buzz everywhere from the New York Times to CNN, but what do they actually mean for you and your family? Dr. Todd Levine will walk us through the science behind these biomarkers, explain who should consider getting tested, and share the honest guidance he’d give his own loved ones when faced with tough decisions. No hype, no sugarcoating, just practical information and real talk to help you navigate the new era of Alzheimer’s prevention and care.

Timestamps:

00:00 FDA approves Alzheimer's blood test

04:12 Detecting Alzheimer's with P Tau 217

10:26 Understanding Alzheimer's Risk Factors

12:36 Determining Alzheimer's with blood tests

15:18 Emerging Alzheimer's treatments and trials

18:25 Advantages of P Tau 217 test

23:38 Discussing Alzheimer’s treatment options

25:48 Discussing genetics and dementia testing

28:21 Value of proactive health testing

31:35 Discussing Alzheimer's blood tests

Dr. Todd Levine on LinkedIn - https://www.linkedin.com/in/todd-levinemd/

Neuro Concierge - https://neuro-concierge.com/

Podcast - https://what-id-tell-my-family.beam.ly/

What I´d Tell My Family Podcast on LinkedIn - https://www.linkedin.com/company/what-id-tell-my-family/

Podcast Partner - https://www.tophealth.care/

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”